Research highlights. PI3K/AKT/mTOR inhibitors would require PI3KCA-mutation analysis
Pharmacogenomics
.
2011 Oct;12(10):1382.
Authors
Chiara Lucchetti
1
,
Flavio Rizzolio
,
Matteo Castronovo
,
Giuseppe Toffoli
Affiliation
1
Sbarro Research Institute, College of Science & Technology, Temple University, Philadelphia, PA 19122, USA.
PMID:
22121542
No abstract available
Publication types
Comment